Pages that link to "Q77318966"
Jump to navigation
Jump to search
The following pages link to C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries (Q77318966):
Displaying 50 items.
- The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen (Q22252194) (← links)
- C-reactive protein: a critical update (Q24672855) (← links)
- Effect of the G-308A polymorphism of the tumor necrosis factor (TNF)-alpha gene promoter site on plasma levels of TNF-alpha and C-reactive protein in smokers: a cross-sectional study (Q24791174) (← links)
- C-reactive protein in human atherogenesis: facts and fiction (Q27013635) (← links)
- Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels (Q28196720) (← links)
- Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. (Q30475959) (← links)
- Cardiovascular disease could be contained based on currently available data! (Q31164692) (← links)
- C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression (Q33365792) (← links)
- The Karachi intracranial stenosis study (KISS) Protocol: an urban multicenter case-control investigation reporting the clinical, radiologic and biochemical associations of intracranial stenosis in Pakistan (Q33482477) (← links)
- Functional analysis of the C-reactive protein (CRP) gene -717A>G polymorphism associated with coronary heart disease (Q33485550) (← links)
- Animal models of C-reactive protein (Q33607563) (← links)
- Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life (Q33735189) (← links)
- C-reactive protein-mediated vascular injury requires complement. (Q33961757) (← links)
- Novel markers of peripheral arterial disease (Q33984026) (← links)
- Microorganisms in the aetiology of atherosclerosis. (Q34065709) (← links)
- High sensitivity C-reactive protein predicts the development of new carotid artery plaques in older persons (Q34138655) (← links)
- C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids (Q34191416) (← links)
- Comorbidity in rheumatoid arthritis. (Q34275967) (← links)
- The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice (Q34297184) (← links)
- Evidence for C-reactive protein's role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP. (Q34340622) (← links)
- C-reactive protein, inflammation, and innate immunity (Q34397073) (← links)
- Inflammation in acute coronary syndromes. (Q34532851) (← links)
- Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation (Q34727136) (← links)
- CRP and the risk of atherosclerotic events. (Q34979165) (← links)
- The possible role of complement activation in Alzheimer disease (Q34991850) (← links)
- C-reactive protein and atherogenesis: new insights from established animal models (Q35085254) (← links)
- High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients. (Q35131398) (← links)
- C-reactive protein and risk of cardiovascular disease: evidence and clinical application (Q35197097) (← links)
- Co-morbidity in rheumatoid arthritis (Q35198206) (← links)
- Alcohol inflammation and coronary heart disease (Q35226413) (← links)
- Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases (Q35231861) (← links)
- Oxidized low density lipoprotein and innate immune receptors (Q35539441) (← links)
- Role of complement activation in atherosclerosis (Q35539458) (← links)
- Atherosclerotic cardiovascular disease in rheumatoid arthritis (Q35553376) (← links)
- C-reactive protein: a surrogate risk marker or mediator of atherothrombosis? (Q35558793) (← links)
- Innate Immunity, Local Inflammation, and Degenerative Disease (Q35577700) (← links)
- Metrics for assessing cytoskeletal orientational correlations and consistency (Q35596601) (← links)
- Hormone therapies and vascular outcomes: who is at risk? (Q35647802) (← links)
- Generation of C-reactive protein and complement components in atherosclerotic plaques (Q35746446) (← links)
- Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction (Q35769679) (← links)
- The role of complement activation in atherosclerosis (Q35838666) (← links)
- Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease (Q35844023) (← links)
- C-reactive protein in vulnerable coronary plaques (Q36014383) (← links)
- Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis (Q36070412) (← links)
- Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension? (Q36133160) (← links)
- Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis (Q36134214) (← links)
- The pro-atherogenic effects of macrophages are reduced upon formation of a complex between C-reactive protein and lysophosphatidylcholine (Q36423484) (← links)
- Garlic-Derived Organic Polysulfides and Myocardial Protection (Q36498005) (← links)
- Association of Periodontal Diseases with Elevation of Serum C-reactive Protein and Body Mass Index (Q36498281) (← links)
- Restenosis after percutaneous angioplasty: the role of vascular inflammation (Q36743813) (← links)